Captrust Financial Advisors Care Dx, Inc. Transaction History
Captrust Financial Advisors
- $33 Billion
- Q3 2024
A detailed history of Captrust Financial Advisors transactions in Care Dx, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 8,682 shares of CDNA stock, worth $183,797. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,682Holding current value
$183,797% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$96 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$66.6 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$63.3 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$43.1 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.13B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...